Browse Guides  internal medicine  cardiology

Infective endocarditis

Prevalence
Clinical features
Investigations
Therapy
Prevention
Prognosis
Clinical features

Ask about
  • valvular heart disease b (including mitral valve prolapse) b
    • which valves are affected b
    • severity of disease b
    • any recent valvular surgery in the last 2 months a
    • any prosthetic valves b
  • previous rheumatic fever b
  • previous endocarditis b
  • intravenous drug use b
  • any infectious episode in the last 3 months b particularly superficial wound infections a
  • any skin wounds in the last 3 months b  
Ask about any skin wounds in the last 3 months b

Note:

  • Recent dental, surgical or medical procedures do not clearly predict an increased risk of developing infective endocarditis. b


Why?

Valvular heart disease, valvular surgery or previous endocarditis increases the risk of developing infective endocarditis

Outcome b Risk Factor PEER OR
(95% CI)
NNH
(95% CI)
infective endocarditis
severe valvular heart disease (mixed or prosthetic valves)
independent
0.0050% 131
(6.9 to 2490)
160
(9 to 3400)

cardiac valvular surgery
independent
0.0050% 74.6
(12.5 to 447)
270
(46 to 1700)

previous episode of endocarditis
independent
0.0050% 37.2
(4.4 to 317)
550
(64 to 5900)

known mitral valve prolapse
independent
0.0050% 19.4
(6.4 to 58.4)
1100
(350 to 3700)

any cardiac valvular abnormality
independent
0.0050% 16.7
(7.4 to 37.4)
1300
(550 to 3100)

rheumatic fever
independent
0.0050% 13.4
(4.5 to 39.5)
1600
(520 to 5700)
 
infectious episode
independent
0.021% 3.9
(2.1 to 7.3)
1600
(760 to 4300)
  skin wound
independent
0.021% 3.9
(1.6 to 9.6)
1600
(560 to 7900)
  congenital heart disease
independent
0.0050% 6.7
(2.3 to 19.4)
3500
(1100 to 15000)
  heart murmur
independent
0.0050% 4.2
(2.0 to 8.9)
6300
(2500 to 20000)
  any dental procedure
independent
0.0050% 1.4
(0.7 to 2.7)
50000
(-67000 to 12000)


Prosthetic valves, wound infections, hypoxia and active endocarditis increase the risk of infective endocarditis following valve surgery

Patient Prognostic Factor Outcome CER RR
(95% CI)
NNF+
(95% CI)
prosthetic valve replacement in last 2 months a superficial wound infection
independent
infective endocarditis
at 8 years
1.3%
(0.7% to 2.0%)
3.5 9
 
  preoperative hypoxia (pO2 < 80 mmHg)
independent
infective endocarditis
at 8 years
1.3%
(0.7% to 2.0%)
7.9 11
 
  active endocarditis
independent
infective endocarditis
at 8 years
1.3%
(0.7% to 2.0%)
6.8 13
  resident as primary surgeon
independent
infective endocarditis
at 8 years
1.3%
(0.7% to 2.0%)
3.2 34
 
  preoperative valve lesion
independent
infective endocarditis
at 8 years
1.3%
(0.7% to 2.0%)

 

Expiry date: July 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , C   Hennigan , S   Dhingra
Reviewer   E   Abrutyn
CAT Writers   CM   Ball , C   Hennigan , S   Dhingra